HO-1197 inhibited key mesenchymal markers, impaired endothelial tube formation, and attenuated VEGF/VEGFR2 and Snail expression—suggesting that it may disrupt tumor-stroma crosstalk and vascular support systems essential for metastatic progression. This evidence concerns the gene VEGFA and neoplasm.